These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 20939796

  • 1. Protein kinase C inhibitors in the treatment of diabetic retinopathy. Review.
    Gálvez MI.
    Curr Pharm Biotechnol; 2011 Mar 01; 12(3):386-91. PubMed ID: 20939796
    [Abstract] [Full Text] [Related]

  • 2. Ruboxistaurin: LY 333531.
    Drugs R D; 2007 Mar 01; 8(3):193-9. PubMed ID: 17472415
    [Abstract] [Full Text] [Related]

  • 3. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
    PKC-DRS2 GroupBeetham Eye Institute, Joslin Diabetes Center, 1 Joslin Place, Boston, MA 02215, USA. LPAiello@Joslin.Harvard.edu, Aiello LP, Davis MD, Girach A, Kles KA, Milton RC, Sheetz MJ, Vignati L, Zhi XE.
    Ophthalmology; 2006 Dec 01; 113(12):2221-30. PubMed ID: 16989901
    [Abstract] [Full Text] [Related]

  • 4. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial.
    PKC-DMES Study Group.
    Arch Ophthalmol; 2007 Mar 01; 125(3):318-24. PubMed ID: 17353401
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of ruboxistaurin (RBX) On visual acuity decline over a 6-year period with cessation and reinstitution of therapy: results of an open-label extension of the Protein Kinase C Diabetic Retinopathy Study 2 (PKC-DRS2).
    Sheetz MJ, Aiello LP, Shahri N, Davis MD, Kles KA, Danis RP, Mbdv Study Group.
    Retina; 2011 Jun 01; 31(6):1053-9. PubMed ID: 21386766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PKC inhibition and diabetic microvascular complications.
    Clarke M, Dodson PM.
    Best Pract Res Clin Endocrinol Metab; 2007 Dec 01; 21(4):573-86. PubMed ID: 18054736
    [Abstract] [Full Text] [Related]

  • 13. Ruboxistaurin mesilate hydrate for diabetic retinopathy.
    Schwartz SG, Flynn HW, Aiello LP.
    Drugs Today (Barc); 2009 Apr 01; 45(4):269-74. PubMed ID: 19499092
    [Abstract] [Full Text] [Related]

  • 14. The potential role of PKC beta in diabetic retinopathy and macular edema.
    Aiello LP.
    Surv Ophthalmol; 2002 Dec 01; 47 Suppl 2():S263-9. PubMed ID: 12507628
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
    Sahu AK, Majji AB.
    Invest Ophthalmol Vis Sci; 2010 Dec 01; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.